G.V.R.K. Sharma Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Biography and Research Information
OverviewAI-generated summary
G.V.R.K. Sharma's research focuses on clinical investigations within gastroenterology and hematology. His work has examined the association between pharmacologic anticoagulation and the risk of recurrent venous thromboembolic events in patients using Janus kinase inhibitors, particularly in those with a history of thrombosis. Sharma has also studied the onset of acute venous thromboembolism in patients treated with specific Janus kinase inhibitors, comparing upadacitinib and tofacitinib. Additionally, his research includes meta-analyses on the efficacy of immunomodulator addition to infliximab monotherapy for inflammatory bowel disease, aiming to restore clinical response. Gender differences in the authorship of gastroenterology clinical practice guidelines have also been a subject of his recent publications. Sharma has a publication record of 51 papers, with an h-index of 15 and over 900 citations.
Metrics
- h-index: 15
- Publications: 51
- Citations: 905
Selected Publications
-
Gender Differences in the Authorship of Gastroenterology Clinical Practice Guidelines (2025)
-
S1340 Reactive Combination Therapy by Addition of an Immunomodulator to Infliximab Monotherapy Restores Pharmacologic and Clinical Response in Inflammatory Bowel Disease: A Case Series, Systematic Review, and Meta-Analysis (2024)
-
Reactive Immunomodulator Addition to Infliximab Monotherapy Restores Clinical Response in Inflammatory Bowel Disease: A Meta-Analysis (2024)
-
Earlier onset of acute venous thromboembolism with upadacitinib compared with tofacitinib during Janus kinase inhibitor therapy (2024)
-
Pharmacologic Anticoagulation Is Associated With a Lower Risk of Recurrent Venous Thromboembolic Events During Janus Kinase Inhibitor Use for Patients With a Prior Thrombosis (2024)
Similar Researchers
Based on overlapping research topics